Prothena Corporation Plc Appoints Chad Swanson As Chief Development Officer and Hideki Garren Pursues Opportunity At Another Company
Prothena Corporation Plc Appoints Chad Swanson As Chief Development Officer and Hideki Garren Pursues Opportunity At Another Company
09/27/24, 9:03 PM
Location
dublinIndustry
therapeutics
biotechnology
health care
Position
chief development officer
Prothena Corporation plc announced the appointment of Chad Swanson, Ph.D., as Chief Development Officer, succeeding Hideki Garren, M.D., Ph.D. Hideki Garren, M.D., Ph.D., will pursue an opportunity at a large pharmaceutical company to lead a global product development division. Prothena will also initiate a search for a world-class healthcare leader as the next Chief Medical Officer.
Company Info
Location
dublin, dublin, ireland
Additional Info
Prothena Corporation plc is a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise. The company is focused on advancing a promising pipeline in neurodegenerative and rare peripheral amyloid diseases, guided by patient-focused drug development.